Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Lilly reports positive results from two Phase lll trials of URLi

Autoimmune attack in type 1 diabetes. Credit: Manu5.

Go Top